Articles

Predictive value of minimal residual disease in Philadelphia-chromosome-positive acute lymphoblastic leukemia treated with imatinib in the European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia, based on immunoglobulin/T-cell receptor and BCR/ABL1 methodologies

Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP), Centro Ricerca Tettamanti, Pediatric Department, University of Milano-Bicocca, Monza, Italy
Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP), Centro Ricerca Tettamanti, Pediatric Department, University of Milano-Bicocca, Monza, Italy;European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia (EsPhALL) Trial Data Center, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
Berlin-Frankfurt-Münster Group Germany (BFM-G), Germany and Switzerland
Berlin-Frankfurt-Münster Group Germany (BFM-G), Germany and Switzerland
Children’s Cancer and Leukaemia Group (CCLG), UK
Children’s Cancer and Leukaemia Group (CCLG), UK
Nordic Society of Paediatric Haematology and Oncology (NOPHO), Sweden, Denmark, Norway, Finland and Iceland
Nordic Society of Paediatric Haematology and Oncology (NOPHO), Sweden, Denmark, Norway, Finland and Iceland
French Acute Lymphoblastic Leukemia Study Groups (French Acute Lymphoblastic Leukemia Study Group, FRALLE and European Organisation for Research and Treatment of Cancer, EORTC), Italy
French Acute Lymphoblastic Leukemia Study Groups (French Acute Lymphoblastic Leukemia Study Group, FRALLE and European Organisation for Research and Treatment of Cancer, EORTC), Italy
Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP), Pediatric Department, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy
Berlin-Frankfurt-Münster Group Germany (BFM-G), Germany and Switzerland
Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP), Pediatric Department, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy
Berlin-Frankfurt-Münster Group Germany (BFM-G), Germany and Switzerland
Dutch Childhood Oncology Group (DCOG), the Netherlands
Dutch Childhood Oncology Group (DCOG), the Netherlands
Czech Pediatric Hematology Working Group (CPH), Czech Republic
Czech Pediatric Hematology Working Group (CPH), Czech Republic
Cooperative study group for treatment of ALL (COALL), Germany
Cooperative study group for treatment of ALL (COALL), Germany
Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP), Azienda Sanitaria Provinciale, Ragusa, Italy
Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP), Pediatric Department, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy
Berlin-Frankfurt-Münster Group Germany (BFM-G), Germany and Switzerland
European intergroup study of post-induction treatment of Philadelphia-chromosome-positive acute lymphoblastic leukemia (EsPhALL) Trial Data Center, School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP), Centro Ricerca Tettamanti, Pediatric Department, University of Milano-Bicocca, Monza, Italy;Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP), Pediatric Department, University of Milano-Bicocca, Fondazione MBBM, Monza, Italy
Vol. 103 No. 1 (2018): January, 2018 https://doi.org/10.3324/haematol.2017.176917